Advertisement
Screener

Co-Diagnostics, Inc. (CODX) Finite-Lived Intangible Asset, Expected Amortization, Year Three

2.8 / 5 stars · 68/120 Roast Me

Co-Diagnostics, Inc. Finite-Lived Intangible Asset, Expected Amortization, Year Three

Co-Diagnostics, Inc. (CODX) had Finite-Lived Intangible Asset, Expected Amortization, Year Three of $302.67 thousand as of 2021-12-31, per its 10-K filed 2022-03-24.

Discontinued › Notes › Goodwill and Other › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity

us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree · last filed 2022-03-24

  • 2021-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year Three $302.67K.
Period endFinite-Lived Intangible Asset, Expected Amortization, Year Three
2021-12-31$302.67K
10-K · filed 2022-03-24

Similar stocks

Stock NameCountryMarket CapPE Ratio
enVVeno Medical Corp (NVNO)United States$0.006B-0.48
Sonoma Pharmaceuticals, Inc. (SNOA)United States$0.006B-2.59
INTELLIGENT BIO SOLUTIONS INC. (INBS)United States$0.005B
AETHLON MEDICAL INC (AEMD)United States$0.005B
Bluejay Diagnostics, Inc. (BJDX)United States$0.004B
OSR Health, Inc. (OSRH)United States$0.004B-0.75
Adagio Medical Holdings, Inc. (ADGM)United States$0.004B
ALLURION TECHNOLOGIES, INC. (ALUR)United States$0.010B
Autonomix Medical, Inc. (AMIX)United States$0.004B
Picard Medical, Inc. (PMI)United States$0.011B-0.01